Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 230–230 | Cite as

Multiple drugs

Developement of drug resistance and recurrent Candida auris candidaemia: case report
Case report
  • 90 Downloads
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

A 54-year-old man developed recurrent Candida auris candidaemia during treatment with micafungin, ciprofloxacin, amoxicillin/clavulanic acid and daptomycin and drug resistance during treatment with micafungin.

The man presented to a hospital from a nursing home with concerns of sepsis on multiple occasions over a period of 5 months (current admission). Before this admission, he had undergone a prolonged hospitalisation at an outside hospital (OSH). A day before the current admission, he was discharged from the OSH. His medical history included quadriplegia, multiple chronic wounds, osteomyelitis of the right hip with abscess formation, deep venous thrombosis, chronic tracheostomy, chronic indwelling, urinary catheter, enteric feeding tube, and colostomy. During hospitalisation...

Reference

  1. Biagi MJ, et al. Development of high-level echinocandin resistance in a patient with recurrent candida auris candidemia secondary to chronic candiduria. Open Forum Infectious Diseases 6: 262, No. 7, 5 Jun 2019. Available from: URL: https://doi.org/10.1093/ofid/ofz262 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations